Viral Vector Manufacturing—Design Considerations to Improve Commercial Success.

14 December 2020

DPS Group Global’s Ryan McDonough, PE was part of an impressive thought leadership panel for Frost & Sullivan, which authored “Viral Vector Manufacturing—Design Considerations to Improve Commercial Success.” This whitepaper is a quick guide on current challenges and trends influencing design considerations for viral vector manufacturing facilities and how they can impact companies developing cell and gene therapies. Learn about the three impactful trends and criteria that will influence the future of viral vector manufacturing.

Read the article